Remotely-supervised transcranial direct current stimulation (tDCS) for at-home treatment of fatigue and cognitive slowing in Parkinson s disease. A pilot study

Brief description of study

The purpose of this study is to test remotely-supervised (at-home) transcranial direct current stimulation (tDCS) to lessen fatigue and slowed thinking in PD when combined with a computerbased cognitive (mental) training program and to see how well the stimulation can be done in a home-setting. Fatigue and slowed thinking are very prevalent symptoms in people with Parkinson's disease (PD). To date there are no concrete effective treatments available for either symptom. tDCS is a relatively safe, well-tolerated procedure that utilizes mild electrical current administered through a headset with 2 pads in contact with your scalp. It has been tested to improve problems like insomnia, pain and depression. The device used to administer tDCS in this study is called the Soterix Mini-CT. This device is considered investigational because it is not approved by the US Food and Drug Administration (FDA) for commercial use. Other similar electric stimulator devices have FDA approval; however, not for people with Parkinson's.


Clinical Study Identifier: s17-00486
ClinicalTrials.gov Identifier: NCT03189472
Principal Investigator: Patrick Drummond.


Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.